Health Trials

Full-Avoidance vs. Permissive/Regulated Drinking & Outcomes On Fibrillation

ConditionsAtrial Fibrillation (AF)Atrial Fibrillation (Paroxysmal)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorUniversity of California, San Francisco

About this trial

The goal of this study is to assess the short-term effects of minimal and moderate drinking on atrial fibrillation (AFib) episodes in a real-world population diagnosed with 'come-and-go'/paroxysmal AFib. The question it aims to answer is:

Is there a greater occurrence of AFib episodes when participants are allowed to consume alcohol according to random assignment?

Participants will:

* Be given daily random assignments to avoid or not to avoid alcohol * Wear an adhesive electrocardiographic (ECG) heart monitor * Wear a wrist-worn fitness tracker * Wear an anklet transdermal alcohol monitor * Wear an adhesive glucose monitor * Complete morning and evening surveys daily

Participants may be compensated up to $50 for full completion of the study. This study can be done in-person or remote.

Eligibility criteria

Qualifiers

Comfortable reading and writing in English

Have a smartphone and willing and able to use the Eureka mobile application

Currently diagnosed with paroxysmal AFib without a plan to change their AFib management during the two-week monitoring period

At least one episode of AFib in the past month OR, in the judgement of a healthcare provider, could potentially have one episode of AF in the next month

Disqualifiers

Only post-operative AFib

Greater than 40% ventricular pacing

History of alcohol addiction or abuse determined by self-reported history or AUDIT-C score

Intolerance to alcohol

Trial design

Treatments tested in this trial

  • Alcohol Consumption Randomized Instructions

Treatment groups

100 Participants
are divided into 2 treatment groups

Locations

2
UCSF Medical Center at Mission Bay94158, San FranciscoCalifornia, United States
UCSF Medical Center at Parnassus94143, San FranciscoCalifornia, United States

Sponsors and collaborators

University of California, San Francisco

Lead sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator

Source ClinicalTrials.gov